Primary Esophageal Angiosarcoma

Lily Gutnik; Eric Goold; Jared Madsen; Frederic Clayton; Thomas Varghese; Robert Glasgow

doi:10.1016/j.athoracsur.2020.07.087

Primary Esophageal Angiosarcoma

Ann Thorac Surg. 2021 May;111(5):e365-e367. doi: 10.1016/j.athoracsur.2020.07.087. Epub 2020 Oct 20.

Authors

Lily Gutnik¹, Eric Goold², Jared Madsen³, Frederic Clayton², Thomas Varghese⁴, Robert Glasgow⁴

Affiliations

¹ Department of Surgery, University of Utah, Salt Lake City, Utah. Electronic address: [email protected].
² Department of Pathology, University of Utah, Salt Lake City, Utah.
³ School of Medicine, University of Utah, Salt Lake City, Utah.
⁴ Department of Surgery, University of Utah, Salt Lake City, Utah.

PMID: 33096067
DOI: 10.1016/j.athoracsur.2020.07.087

Abstract

Primary esophageal angiosarcoma is an extremely rare cancer. Thus, evidence-based guidance on diagnosis and treatment is lacking. The current workup and management is extrapolated from other esophageal and angiosarcoma pathology. We describe a case report that depicts unique diagnostic and therapeutic challenges.

Publication types

Case Reports

MeSH terms

Biopsy
Combined Modality Therapy / methods
Endoscopy, Gastrointestinal / methods
Endosonography
Esophageal Neoplasms / diagnosis*
Esophageal Neoplasms / therapy
Female
Hemangiosarcoma / diagnosis*
Hemangiosarcoma / therapy
Humans
Middle Aged